Last reviewed · How we verify

NCT06327802: MucoZar

Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment

Recruiting now Last updated 2 May 2024
What this trial tests

trial testing Questionnaire in Cystic Fibrosis in 360 participants. Currently enrolling.

Timeline
1 April 2024
Primary endpoint
31 December 2024
31 July 2025

Quick facts

Lead sponsorPole Sante Grace de Dieu
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment360
Start date1 April 2024
Primary completion31 December 2024
Estimated completion31 July 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Pole Sante Grace de Dieu

Who can join

18 and older, any sex, with Cystic Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the study is to determine the impact of cystic fibrosis affecting a child on the parents' quality of life, their possible anxiety and depressive symptoms, their general fatigue and the feeling of burden in these caregivers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Cystic Fibrosis

Currently open trials in the same condition.

Other Pole Sante Grace de Dieu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06327802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing